Gene Query: GFOD1

Dataset Description Geneva Score
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 62.34
ARID1A regulates condensin II distribution and chromosomal partition 55.16
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 55.16
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 51.82
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 48.07
Comparison of microRNA Profiling Platforms (HTS) 47.82
Comparison of microRNA Profiling Platforms 47.82
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 38.78
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 38.75
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 38.75
Differential gene expression profiles in imatinib-resistant cell lines 38.25
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 34.84
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 34.84
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 30.44
BET bromodomain inhibition 30.44
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 30.05
RNA-Seq from human ILC transitional populations 28.76
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 28.76
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 28.09
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 28.09
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 26.97
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 25.61
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 25.33
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 25.06
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 24.72
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 24.58
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 24.57
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 22.31
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 22.28
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 22.28
The cytokine environment influence on human skin-derived T cells 21.86
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 21.19
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 20.85
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 20.84
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 18.74
Primary Human B-cell Temporal Response to CD40L Stimulation 18.7
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 17.86
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 17.58
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 17.46
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 17.03
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 17.03
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 16.56
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 16.46
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 16.39
Cleavage Factor Im as a key regulator of 3’ UTR length 16.24
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 16.06
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 15.69
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 15.67
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 15.54
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 15.52
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 15.4
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 15.38
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 15.21
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 14.91
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 14.74
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 14.47
Transcriptome of activated human and mouse MAIT cells 14.43
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 14.15
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 13.83
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 13.55
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 13.16
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 13.05
circRNA-sequencing 12.44
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 12.06
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 11.84
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 11.76
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 11.69
Differential Gene Expression between MCF10A and MCF7 cells 11.59
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 11.34
Transcriptome analysis of kidney organoids 11.22
Hepatosplenic T cell lymphoma 11.17
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 11.17
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 11.12
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 11.12
Leucegene: AML sequencing (part 6) 11.08
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 11.0
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 10.88
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 10.87
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 10.76
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 10.7
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 10.5
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 10.43
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 10.31
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 10.23
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 10.15
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 10.13
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 10.07
LIN28A Over-expression RNAseq 9.94
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 9.88
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 9.88
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 9.84
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 9.84
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 9.83
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 9.67
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 9.5
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 9.37
Role of microRNAs in the interaction between Salmonella and the host cell 9.28
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 9.2
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 9.2
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 9.0
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 8.89
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 8.87
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 8.86
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 8.62
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 8.61
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 8.6
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 8.6
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 8.6
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 8.59
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 8.58
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 8.58
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 8.53
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 8.47
RNA-Seq in neutrophils from Antiphospholipid Syndrome 8.46
The evolution of N6-methyladenosine in primates 8.42
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 8.42
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 8.42
The Glioma-Infiltrating T Cell Receptor Repertoire 8.23
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 8.19
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 8.16
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 8.14
Developmental stage specific chromosome architecture in human erythroid cells 8.14
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 8.08
Global epigenomic reconfiguration during mammalian brain development 8.0
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 7.9
RNA expression following TMPRSS11B overexpression or depletion 7.89
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 7.88
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 7.76
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 7.76
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 7.75
Human Tfh cell RNA bulk sequencing 7.73
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 7.66
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 7.64
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 7.6
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 7.5
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 7.49
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 7.49
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 7.38
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 7.38
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 7.31
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 7.29
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 7.27
In situ CAPTURE of chromatin interactions by biotinylated dCas9 7.27
Clinker: visualizing fusion genes detected in RNA-seq data 7.2
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 7.16
Irf9 function in immunity in mouse 7.16
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 7.13
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 7.11
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 7.1
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 7.1
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 7.08
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 7.08
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 7.07
Macrophage Ad5f35 M2 Challenge 7.06
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 7.05
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 7.04
The comparison of high-throughput single-cell RNA-seq methods 6.97
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.91
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 6.91
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 6.81
Primate transcript and protein expression levels evolve under compensatory selection pressures 6.79
Characterization of human ILC2 subsets 6.77
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 6.76
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 6.75
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 6.75
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 6.69
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 6.69
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 6.67
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 6.64
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 6.62
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 6.61
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 6.61
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 6.54
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 6.53
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 6.53
A Unique Epigenomic Landscape Defines Human Erythropoiesis 6.52
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 6.52
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.49
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 6.38
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 6.34
Expression profiles of the four human major ectodermal lineages 6.28
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 6.23
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 6.22
RNA-seq analysis and shRNA screen of breast cancer 6.16
RNA-seq analysis of breast cancer 6.16
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.13
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.13
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 6.12
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 6.12
Stem and effector CD8 T-cells from human cancers 6.11
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 6.03
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 6.02
The age and genomic integrity of neurons after cortical stroke in humans 5.98
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 5.96
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.9
Gene expression changes associated with resistance to tagraxofusp (SL-401) 5.79
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 5.78
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 5.77
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 5.75
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 5.69
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.69
Identification of global regulators of T-helper cell lineage specification 5.68
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 5.68
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 5.67
RNA-seq of MDA-MB-231 cells with TET1 knockout 5.67
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 5.59
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 5.55
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 5.53
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 5.53
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 5.52
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 5.52
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 5.49
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 5.48
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.47
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 5.46
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 5.43
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 5.43
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 5.42
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 5.42
U1 snRNP telescripting regulates size-function stratified human genome 5.41
Selective suppression of endothelial cytokine production by progesterone receptor 5.37
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 5.37
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 5.29
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 5.27
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 5.26
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 5.25
Genes significantly down or Up-regulated upon RNF219 knockdown 5.2
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 5.2
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 5.17
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.17
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.17
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 5.14
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 5.12
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 5.1
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 5.1
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.04
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 5.02
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 4.98
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 4.98
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 4.98
Universal alternative splicing of noncoding exons 4.96
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 4.94
The expression profiles of GBC liver metastasis 4.92
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 4.87
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 4.87
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 4.85
Primary human trophoblast from term placenta 4.84
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 4.79
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 4.79
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 4.78
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 4.76
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.76
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 4.75
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 4.72
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 4.7
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 4.7
Effect of nuclear IL-33 on gene expression 4.69
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 4.66
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 4.64
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 4.64
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 4.61
Genome-wide mapping of TEL-AML1 targets in acute leukemia 4.58
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 4.57
Noncoding regions are the main source of targetable tumor-specific antigens 4.56
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 4.55
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 4.5
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 4.47
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 4.43
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 4.41
Dermal endothelial cells of type 2 diabetic patients 4.39
RNA-seq analysis of control and Myc-induced U2OS cells 4.37
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 4.34
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 4.34
Zone dependent distinctive gene expression profile of the normal human liver tissue 4.28
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 4.21
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 4.21
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 4.2
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 4.18
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 4.04
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 4.04
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 4.03
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 4.03
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 4.01
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 4.0
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 3.99
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.93
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 3.92
Seletive inhibition of CDK9 in DLBCL cell lines 3.92
Genome-wide identification of cancer-specific alternative splicing in circRNA 3.91
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 3.78
LIN28A modulates splicing and gene expression programs in breast cancer cells 3.78
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 3.78
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.77
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 3.76
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 3.76
RNAseq in Alzheimer's Disease patients 3.75
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.75
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.71
Tracing Enhancer Networks using Epigenetic Traits (TENET) 3.59
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 3.58
Recovery and analysis of nascent RNA 3.58
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 3.56
RNA-seq analysis of differentiating human erythroblasts 3.55
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 3.49
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 3.49
TAF1 is critical for AE driven leukemogenesis 3.49
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.47
mRNA recovered upon RNF219 IP. [RNA-IP] 3.43
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 3.41
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.37
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 3.35
Impact on erythroid progenitor type on erythroid differntiation 3.33
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 3.33
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 3.32
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 3.27
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.26
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 3.25
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 3.25
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 3.24
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 3.21
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 3.21
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 3.18
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 3.18
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.16
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 3.14
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 3.14
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.14
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 3.12
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 3.12
MRTF activates TEAD-YAP target gene expression 3.09
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.07
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 3.01
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 3.01
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 3.01
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.0
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 2.95
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.92
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.92
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 2.9
Induction of Cardiomyocyte Proliferation [pz-822_human] 2.9
LINE-2 transposable elements are a source of functional human microRNAs and target sites 2.88
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 2.88
NAPRT activation of macrophages 2.88
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.87
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.87
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.87
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 2.86
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 2.82
Macrophage Ad5f35 PhenoMap 2.8
quanTIseq: quantifying immune contexture of human tumors 2.8
The role of m6A/m-RNA methylation in stress response regulation 2.8
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 2.8
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 2.77
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 2.77
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 2.59
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.57
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.56
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.53
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.5
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 2.48
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 2.46
Zika virus infection reprograms global transcription of host cells to allow sustained infection 2.45
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 2.37
Targeted enhancer activation by a subunit of the integrator complex 2.33
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 2.32
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 2.32
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 2.29
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.24
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.24
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 2.22
Deep RNA sequencing of the human placental transcriptome 2.21
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.18
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 2.18
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 2.17
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.15
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 2.15
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.13
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 2.12
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 2.09
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 2.08
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 2.07
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 2.05
The gene expression profiles of gallbladder cancer 2.03
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 2.02
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 2.01
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 1.9
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 1.9
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.88
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.86
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.84
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.78
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.78
CD74 role in transcription regulation [RNA-seq] 1.77
CD74 role in transcription regulation 1.77
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.77
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 1.74
Modeling Human Cancer-induced Cachexia (Human) 1.72
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.72
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 1.71
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.7
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.69
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.68
Oncogenic roles of ARID5B in T-ALL 1.68
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.63
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 1.6
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.56
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 1.51
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 1.5
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.49
RNA-Seq of the corpus callosum from 12 individuals 1.48
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.46
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 1.41
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.38
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.38
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 1.33
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 1.33
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.31
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.31
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.26
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.26
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.24
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.24
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 1.23
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.2
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 1.2
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.19
oxLDL exposed trained monocytes 1.18
Transcriptomes of oxLDL exposed trained monocytes 1.18
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.16
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 1.11
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.05
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.05
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.05
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.04
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.01
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.97
Fusion discovery in breast cancer cell line 0.97
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.95
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.92
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.91
Transcriptomic profiling of human peripheral blood-derived mast cells 0.91
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.91
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.87
Alteration of the microRNA network during the progression of Alzheimer’s disease 0.85
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 0.82
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.8
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.79
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.75
Human ovarian granulosa cell transcriptome 0.72
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.71
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.71
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.65
KSDM1b Role in Ewing Sarcoma 0.65
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 0.61
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.61
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.6
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.58
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.57
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.56
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.53
RNA sequencing of T-ALL (COG study) 0.52
Analyses of T-ALL (COG study) 0.52
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 0.51
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.51
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.48
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.47
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.47
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.45
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.45
Dilated cardiomyopathy vs Myocarditis 0.42
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.42
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.42
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 0.42
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.38
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 0.34
RNA expression analysis upon JMJD1C depletion 0.34
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.33
Generation and functional characterization of MDSC-like cells 0.33
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.32
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.31
Gene expression activation in CLL mediated by MSCs contact 0.31
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.27
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.26
RNA-seq of primary patient AML samples 0.25
MHC Transcriptomic landscape at haplotype-specific resolution 0.25
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.22
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.18
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 0.18
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.17
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.17
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.14
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.12
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 0.12
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 0.12
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.11
Transcriptomic analysis of human macrophages in 3D 0.05
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.01
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 0.0
Argonaute proteins couple chromatin silencing to alternative splicing 0.0
Transcriptome Profiling of Human Primary Monocytes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation